相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Anetumab ravtansine versus vinorelbine in patients with relapsed, mesothelin-positive malignant pleural mesothelioma (ARCS-M): a randomised, open-label phase 2 trial
Hedy L Kindler et al.
LANCET ONCOLOGY (2022)
A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combination with the Anti-PD-1 Agent Pembrolizumab
Prasad S. Adusumilli et al.
CANCER DISCOVERY (2021)
Mesothelin Enhances Tumor Vascularity in Newly Forming Pancreatic Peritoneal Metastases
Leela Rani Avula et al.
MOLECULAR CANCER RESEARCH (2020)
Multiple proteases are involved in mesothelin shedding by cancer cells
Xiufen Liu et al.
COMMUNICATIONS BIOLOGY (2020)
Biomarker panel predicts survival after resection in pancreatic ductal adenocarcinoma: A multi-institutional cohort study
Christopher B. Nahm et al.
EJSO (2019)
Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group
Aliya Noor Husain et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2018)
Activity of Mesothelin-Specific Chimeric Antigen Receptor T Cells Against Pancreatic Carcinoma Metastases in a Phase 1 Trial
Gregory L. Beatty et al.
GASTROENTEROLOGY (2018)
Integrative Molecular Characterization of Malignant Pleural Mesothelioma
Jutija Hmeljaki et al.
CANCER DISCOVERY (2018)
Co-occurring Mutations of Tumor Suppressor Genes, LATS2 and NF2, in Malignant Pleural Mesothelioma
Robin Tranchant et al.
CLINICAL CANCER RESEARCH (2017)
Mesothelin/mucin 16 signaling in activated portal fibroblasts regulates cholestatic liver fibrosis
Yukinori Koyama et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Tumor Suppressor microRNAs Contribute to the Regulation of PD-L1 Expression in Malignant Pleural Mesothelioma
Steven C. Kao et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
Prognostic significance of soluble mesothelin in malignant pleural mesothelioma: a meta-analysis
Long Tian et al.
ONCOTARGET (2017)
Comprehensive immunohistochemical study of mesothelin (MSLN) using different monoclonal antibodies 5B2 and MN-1 in 1562 tumors with evaluation of its prognostic value in malignant pleural mesothelioma
Shingo Inaguma et al.
ONCOTARGET (2017)
Cancer antigen profiling for malignant pleural mesothelioma immunotherapy: expression and coexpression of mesothelin, cancer antigen 125, and Wilms tumor 1
Takashi Eguchi et al.
ONCOTARGET (2017)
The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesothelioma
Aatur D. Singhi et al.
MODERN PATHOLOGY (2016)
Murine mesothelin: characterization, expression, and inhibition of tumor growth in a murine model of pancreatic cancer
Emmanuel Zervos et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2016)
Phase I Study of DMOT4039A, an Antibody-Drug Conjugate Targeting Mesothelin, in Patients with Unresectable Pancreatic or Platinum-Resistant Ovarian Cancer
Colin D. Weekes et al.
MOLECULAR CANCER THERAPEUTICS (2016)
An RNAi-based screen reveals PLK1, CDK1 and NDC80 as potential therapeutic targets in malignant pleural mesothelioma
A. Linton et al.
BRITISH JOURNAL OF CANCER (2014)
Phase 1 Study of the Antimesothelin Immunotoxin SS1P in Combination With Pemetrexed and Cisplatin for Front-Line Therapy of Pleural Mesothelioma and Correlation of Tumor Response With Serum Mesothelin, Megakaryocyte Potentiating Factor, and Cancer Antigen 125
Raffit Hassan et al.
CANCER (2014)
Expression of Wilms' tumor gene (WT1) is associated with survival in malignant pleural mesothelioma
S. Cedres et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2014)
Phase II Clinical Trial of Amatuximab, a Chimeric Antimesothelin Antibody with Pemetrexed and Cisplatin in Advanced Unresectable Pleural Mesothelioma
Raffit Hassan et al.
CLINICAL CANCER RESEARCH (2014)
Origin of myofibroblasts in the fibrotic liver in mice
Keiko Iwaisako et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Mesothelin Overexpression Promotes Mesothelioma Cell Invasion and MMP-9 Secretion in an Orthotopic Mouse Model and in Epithelioid Pleural Mesothelioma Patients
Elliot L. Servais et al.
CLINICAL CANCER RESEARCH (2012)
Identification and prospective isolation of a mesothelial precursor lineage giving rise to smooth muscle cells and fibroblasts for mammalian internal organs, and their vasculature
Yuval Rinkevich et al.
NATURE CELL BIOLOGY (2012)
Mesothelin confers pancreatic cancer cell resistance to TNF-α-induced apoptosis through Akt/PI3K/NF-κB activation and IL-6/Mcl-1 overexpression
Uddalak Bharadwaj et al.
MOLECULAR CANCER (2011)
Diagnostic Performance of Soluble Mesothelin and Megakaryocyte Potentiating Factor in Mesothelioma
Kevin Hollevoet et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Re-evaluation of histological diagnoses of malignant mesothelioma by immunohistochemistry
Helmut P. Sandeck et al.
DIAGNOSTIC PATHOLOGY (2010)
A Binding Domain on Mesothelin for CA125/MUC16
Osamu Kaneko et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Immunohistochemical marker panels for distinguishing between epithelioid mesothelioma and lung adenocarcinoma
Kei Kushitani et al.
PATHOLOGY INTERNATIONAL (2007)
The use of the monoclonal antibody mesothelin in the diagnosis of malignant mesothelioma in pleural biopsies
ML Galloway et al.
HISTOPATHOLOGY (2006)
New monoclonal antibodies to mesothelin useful for immunohistochemistry, fluorescence-activated cell sorting,Western blotting, and ELISA
M Onda et al.
CLINICAL CANCER RESEARCH (2005)
The diagnostic utility of immunohistochemistry in distinguishing between mesothelioma and renal cell carcinoma:: A comparative study
NG Ordóñez
HUMAN PATHOLOGY (2004)
The immunohistochemical diagnosis of mesothelioma -: A comparative study of epithelioid mesothelioma and lung adenocarcinoma
NG Ordóñez
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2003)
Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma
NJ Vogelzang et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Expression of calretinin, thrombomodulin, keratin 5, and mesothelin in lung carcinomas of different types - An immunohistochemical analysis of 596 tumors in comparison with epithelioid mesotheliomas of the pleura
M Miettinen et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2003)
Mesothelin is not required for normal mouse development or reproduction
TK Bera et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
分享论文
